Table 4.
AD biomarker | Variables | Type of stenosis | B | SE | p |
---|---|---|---|---|---|
Neurodegeneration biomarker | AD-CT | Any extracranial carotid stenosis | − 0.051 | 0.033 | 0.121 |
Any intracranial stenosis | − 0.033 | 0.020 | 0.104 | ||
Number of stenotic intracranial arteries ≥ 2 | − 0.040 | 0.025 | 0.113 | ||
Anterior circulation | − 0.024 | 0.021 | 0.254 | ||
Posterior circulation | − 0.074 | 0.034 | 0.030* | ||
HVa | Any intracranial stenosis | − 30.760 | 95.491 | 0.748 |
Covariates for confirmatory multivariable analyses include age, sex, and APOE4 carrier status. Units for AD biomarker variables are as follows: SUVR for global Aβ, mm for AD-CT, and mm3 for HVa. When Bonferroni-corrected p value (p < 0.05/6 = 0.008) was applied for confirmatory multivariable analyses regarding neurodegeneration biomarkers, these associations were not significant, although posterior circulation stenosis showed a trend for association with reduced AD-CT
AD Alzheimer’s disease, CN cognitively normal, SE standard error, AD-CT Alzheimer’s disease-signature cortical thickness, HVa hippocampal volume adjusted for intracranial volume
aNo significant findings in the exploratory univariable analyses step regarding Aβ biomarker
*p < 0.05 (before Bonferroni correction)